Randomized controlled study of TACE therapy for HCC comparing epi-ADM and CDDP
Phase 3
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-C000000372
- Lead Sponsor
- Department of Internal Medicine Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1)A patient who has severe complications (however chronic hepatitis and liver cirrhosis are excluded for this criteria). 2)A patient who has active double cancers (besides HCC, the double cancers which can decide the prognosis). 3)A patient who has a medical history of severe hyperesthesia. 4)A patient who is pregnant, a nursing mother or is suspected of being pregnant. 5)A patient who is decided by the principal investigator or a clinical investigator not to be an adequate subject for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method